Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Pharma
Biogen CEO's 2023 pay shrank by 87%
After receiving a sign-on package worth $30.5 million, Biogen CEO Chris Viehbacher's 2023 pay shrank to just $4.1 million thanks to a prior agreement.
Angus Liu
Apr 16, 2024 1:00pm
The best returns come from small M&A deals: McKinsey report
Apr 9, 2024 10:45am
Big Pharma CEOs in China, AstraZeneca, WuXi—Fierce Pharma Asia
Mar 29, 2024 10:10am
Eisai, Sumitomo, Kyowa Kirin and more—Fierce Pharma Asia
Mar 8, 2024 9:42am
Viatris still hungry for deals after pact with Idorsia: CEO
Feb 28, 2024 10:45am
In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen
Feb 12, 2024 10:55am